CoChat

Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island

Open access
Arriola Apelo, Sebastian I., Lamming, Dudley W. · 2016 · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
Cited by 239

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Rapamycin (sirolimus) is a macrolide immunosuppressant that inhibits the mechanistic target of rapamycin (mTOR) protein kinase and extends lifespan in model organisms including mice. Although rapamycin is an FDA-approved drug for select indications, a diverse set of negative side effects may preclude its wide-scale deployment as an antiaging therapy. mTOR forms two different protein complexes, mTORC1 and mTORC2; the former is acutely sensitive to rapamycin whereas the latter is only chronically sensitive to rapamycin in vivo. Over the past decade, it has become clear that although genetic and pharmacological inhibition of mTORC1 extends lifespan and delays aging, inhibition of mTORC2 has negative effects on mammalian health and longevity and is responsible for many of the negative side effects of rapamycin. In this review, we discuss recent advances in understanding the molecular and physiological effects of rapamycin treatment, and we discuss how the use of alternative rapamycin treatment regimens or rapamycin analogs has the potential to mitigate the deleterious side effects of rapamycin treatment by more specifically targeting mTORC1. Although the side effects of rapamycin are still of significant concern, rapid progress is being made in realizing the revolutionary potential of rapamycin-based therapies for the treatment of diseases of aging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/gerona/glw090

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 100

  1. 10.7164/antibiotics.28.721 · DOI · Paper page
  2. 10.1139/y77-007 · DOI · Paper page
  3. Dumont, 1990, Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin, J Immunol, 144, 251, 10.4049/jimmunol.144.1.251 · DOI · Paper page
  4. 10.7164/antibiotics.32.630 · DOI
  5. 10.7164/antibiotics.40.1256 · DOI · Paper page
  6. 10.1073/pnas.89.9.3686 · DOI · Paper page
  7. 10.1038/357692a0 · DOI · Paper page
  8. 10.1016/S1874-6047(10)27002-6 · DOI
  9. 10.1146/annurev-nutr-071714-034355 · DOI · Paper page
  10. 10.1186/2193-1801-3-735 · DOI · Paper page
  11. 10.1016/j.cell.2015.02.041 · DOI · Paper page
  12. 10.1126/science.1257132 · DOI · Paper page
  13. 10.1016/j.molcel.2006.03.029 · DOI · Paper page
  14. 10.1111/acel.12313 · DOI · Paper page
  15. 10.1016/0277-5379(83)90012-3 · DOI · Paper page
  16. 10.7164/antibiotics.37.1231 · DOI · Paper page
  17. 10.1126/science.1115535 · DOI · Paper page
  18. 10.1016/j.cmet.2009.11.010 · DOI · Paper page
  19. 10.1101/gad.1381406 · DOI · Paper page
  20. 10.1371/journal.pbio.0050261 · DOI · Paper page
  21. 10.1111/j.1474-9726.2011.00791.x · DOI · Paper page
  22. 10.1111/acel.12203 · DOI · Paper page
  23. 10.1111/j.1474-9726.2012.00832.x · DOI · Paper page
  24. Lin AL Jahrling JB Zhang W . Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease. J Cereb Blood Flow Metab. 2015. doi:10.1177/0271678X15621575 · DOI · Paper page
  25. Bai, 2015, Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathy, Pathobiol Aging Age Relat Dis, 5, 28743, 10.3402/pba.v5.28743 · DOI · Paper page
  26. 10.1158/2159-8290.CD-13-0929 · DOI · Paper page
  27. 10.1158/2159-8290.CD-13-0353 · DOI · Paper page
  28. 10.1093/gerona/glq178 · DOI · Paper page
  29. 10.1111/acel.12194 · DOI · Paper page
  30. Zaseck LW Miller RA Brooks SV . Rapamycin attenuates age-associated changes in tibialis anterior tendon viscoelastic properties. J Gerontol A Biol Sci Med Sci. 2016. doi:10.1093/gerona/glv307 · DOI · Paper page
  31. Carter CS Khamiss D Matheny M . Rapamycin versus intermittent feeding: dissociable effects on physiological and behavioral outcomes when initiated early and late in life. J Gerontol A Biol Sci Med Sci. 2015. doi:10.1093/gerona/glu238 · DOI
  32. Arriola Apelo SI Pumper CP Baar EL Cummings NE Lamming DW . Intermittent administration of rapamycin extends the life span of female C57BL/6J mice. J Gerontol A Biol Sci Med Sci. 2016. doi:10.1093/gerona/glw064 · DOI · Paper page
  33. Fan, 2015, Rapamycin preserves gut homeostasis during Drosophila aging, Oncotarget, 6, 35274, 10.18632/oncotarget.5895 · DOI · Paper page
  34. 10.1016/j.celrep.2013.07.030 · DOI · Paper page
  35. 10.1172/JCI77361 · DOI · Paper page
  36. 10.1210/en.2014-1690 · DOI · Paper page
  37. 10.1111/nyas.12122 · DOI · Paper page
  38. 10.1681/ASN.2007111202 · DOI · Paper page
  39. 10.1097/01.TP.0000056639.74982.F9 · DOI
  40. Sonis, 2010, Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients, Cancer, 116, 210, 10.1002/cncr.24696 · DOI · Paper page
  41. 10.1002/phar.1692 · doi:10.1002/phar.1692
  42. 10.1111/j.1365-2036.2004.01923.x · DOI · Paper page
  43. 10.1016/j.bbmt.2005.04.007 · DOI · Paper page
  44. 10.1097/TP.0b013e31824bf1f0 · DOI
  45. 10.1097/CAD.0000000000000207 · DOI · Paper page
  46. 10.1681/ASN.2005050487 · DOI · Paper page
  47. 10.2337/diabetes.52.11.2731 · DOI · Paper page
  48. 10.1073/pnas.0803047105 · DOI · Paper page
  49. 10.1096/fj.13-237743 · DOI · Paper page
  50. 10.1073/pnas.0811321106 · DOI · Paper page
  51. 10.2337/db09-1061 · DOI · Paper page
  52. 10.1038/ncomms11365 · DOI · Paper page
  53. 10.1128/MCB.01405-07 · DOI · Paper page
  54. 10.1016/j.molmet.2014.06.004 · DOI · Paper page
  55. 10.2337/db10-1194 · DOI · Paper page
  56. 10.1016/j.molmet.2014.01.014 · DOI · Paper page
  57. 10.1002/cne.23668 · DOI
  58. 10.1152/ajpendo.00110.2012 · DOI · Paper page
  59. 10.1084/jem.20071477 · DOI · Paper page
  60. Byles, 2013, The TSC-mTOR pathway regulates macrophage polarization, Nature Commun, 4, 2834, 10.1038/ncomms3834 · DOI · Paper page
  61. 10.4049/jimmunol.1400188 · DOI · Paper page
  62. 10.1371/journal.pone.0095432 · DOI · Paper page
  63. Covarrubias AJ Aksoylar HI Yu J . Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation. eLife. 2016;5. doi:10.7554/eLife.11612 · DOI · Paper page
  64. 10.1371/journal.pone.0016144 · DOI · Paper page
  65. 10.1093/gerona/54.11.B492 · DOI · Paper page
  66. 10.1186/2046-2395-1-3 · DOI · Paper page
  67. Lamming DW Anderson RM . Metabolic Effects of Caloric Restriction. Chichester, UK: John Wiley & Sons; 2014. · DOI · Paper page
  68. 10.1111/acel.12256 · DOI · Paper page
  69. 10.1111/acel.12425 · DOI · Paper page
  70. Lind MI Zwoinska MK Meurling S Carlsson H Maklakov AA . Sex-specific tradeoffs with growth and fitness following life-span extension by rapamycin in an outcrossing nematode, Caenorhabditis remanei . J Gerontol A Biol Sci Med Sci. 2015. doi:10.1093/gerona/glv174 · DOI
  71. 10.18632/aging.100401 · DOI
  72. 10.18632/aging.100461 · DOI · Paper page
  73. 10.4161/cc.10.24.18486 · DOI · Paper page
  74. Scarpace PJ Matheny M Strehler KY . Rapamycin normalizes serum leptin by alleviating obesity and reducing leptin synthesis in aged rats. J Gerontol A Biol Sci Med Sci. 2015. doi:10.1093/gerona/glu230 · DOI
  75. 10.1007/s00109-011-0834-3 · DOI · Paper page
  76. 10.1067/mcp.2001.112513 · DOI
  77. 10.1111/acel.12211 · DOI · Paper page
  78. 10.1093/gerona/glt056 · DOI · Paper page
  79. 10.1042/CS20150149 · DOI
  80. 10.1016/j.clgc.2014.07.006 · DOI
  81. 10.1016/j.transproceed.2004.01.015 · DOI
  82. 10.1016/j.diabres.2015.09.014 · DOI
  83. 10.1634/theoncologist.2010-0222 · DOI · Paper page
  84. 10.1177/0300985815591082 · DOI · Paper page
  85. 10.1038/514546a · DOI
  86. 10.1016/j.bbmt.2014.06.004 · DOI
  87. 10.1097/00007890-199604270-00015 · DOI · Paper page
  88. Tran CM Mukherjee S Ye L . Rapamycin blocks induction of the thermogenic program in white adipose tissue. Diabetes. 2016. doi:10.2337/db15-0502 · DOI · Paper page
  89. 10.1038/nbt.3163 · DOI
  90. 10.1371/journal.pone.0083988 · DOI · Paper page
  91. 10.1038/nm1560 · DOI · Paper page
  92. 10.2353/ajpath.2010.091050 · DOI · Paper page
  93. 10.1016/j.neurobiolaging.2011.06.002 · DOI
  94. 10.18632/aging.100498 · DOI · Paper page
  95. 10.18632/aging.100496 · DOI · Paper page
  96. 10.18632/aging.100533 · DOI · Paper page
  97. 10.18632/aging.100633 · DOI · Paper page
  98. 10.4161/cbt.28164 · DOI · Paper page
  99. Johnson, 2015, Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice, Front Genet, 6, 247, 10.3389/fgene.2015.00247 · DOI · Paper page
  100. 10.1111/acel.12380 · DOI · Paper page

Cited by

See all 239

Metadata

Authors
Arriola Apelo, S. I., & Lamming, D. W.
Venue
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
Published
2016-05-21
Volume
71
Issue
7
Pages
841-849
ISSN
  • 1079-5006 (ISSN-L)
  • 1758-535X
OpenAlex
W2395395500
Cited by
239
References
26
FWCI
7.90
Type
journal article
Language
en
Open access
bronze
Funders
  • National Institute on Aging
  • National Institutes of Health (R00 AG041765)
  • University of Wisconsin–Madison School of Medicine and Public Health
  • American Diabetes Association (1-16-PMF-001)
  • American Federation for Aging Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.